AKT1 and prostate cancer: miR-93-5p has been demonstrated to directly target DAB2 to promote cell migration and invasion in prostate cancer 23, and it can also regulate cell migration and invasion by suppressing PTEN through the PI3K/Akt pathway in breast cancer 24.